Trade Summary

1 month ago, Novo Holdings A/S, serving as 10% owner at Avalyn Pharma Inc. (AVLN), purchased 555,555 shares at $18.00 per share, for a total transaction value of $9,999,990.00. Following this transaction, Novo Holdings A/S now holds 3,883,289 shares of AVLN.

This purchase represents a 17.00% increase in Novo Holdings A/S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026 at 4:15 PM ET, 4 days after the trade was made.

Avalyn Pharma Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.